Gilead, Emory Abandon Patent Case Over HIV Drug

Gilead and Emory University have dropped lawsuits against Hetero Drugs over an ANDA related to a generic HIV drug.

Court documents do not state why the case is being dropped, only that it is dismissed with prejudice.

Gilead and Emory filed two cases in New Jersey less than a month ago claiming that Hetero’s ANDA infringed on four of Gilead’s and Emory’s patents related to its Truvada drug.

The two suits claimed that the active ingredients in Truvada are the same in Hetero’s generic and that Hetero’s notice letter did not provide a full and detailed statement of Hetero’s factual and legal basis to support its non-infringement and invalidity allegations for any of the four patents.